← FDA Drug Approvals (Drugs@FDA)

NADOLOL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RK PHARMA · Approved 2019-09-13

Drug application

FDA Application #

ANDA212856

Application type

Abbreviated New Drug Application (Generic)

Brand name

NADOLOL

Generic name

NADOLOL

Active ingredients

NADOLOL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

RK PHARMA

Manufacturer

VGYAAN Pharmaceuticals LLC

First approval

2019-09-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown